{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:02:07Z","timestamp":1793444527887,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":1385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Association of Angiodysplasias"},{"name":"Childhood Hemangiomas"},{"name":"Telethon Italy"},{"name":"EuroBioBank"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvsvenous.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jvsv.2020.07.015","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:53:31Z","timestamp":1598417611000},"page":"740-744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy"],"prefix":"10.1016","volume":"9","author":[{"given":"Maria","family":"Palmieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Di Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tommasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Curr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Doddato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Baldassarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Frullanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Giliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fallerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Arzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Vaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0846-9220","authenticated-orcid":false,"given":"Alessandra","family":"Renieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2020.07.015_bib1","doi-asserted-by":"crossref","first-page":"a009688","DOI":"10.1101\/cshperspect.a009688","article-title":"Vascular anomalies: from genetics toward models for therapeutic trials","volume":"2","author":"Uebelhoer","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jvsv.2020.07.015_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0092-8674(00)81814-0","article-title":"Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2","volume":"87","author":"Vikkula","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jvsv.2020.07.015_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ejhg.2009.193","article-title":"Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects","volume":"18","author":"Wouters","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jvsv.2020.07.015_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12952-017-0072-5","article-title":"Facial cutaneo-mucosal venous malformations can develop independently of mutation of TEK gene but may be associated with excessive expression of Src and p-Src","volume":"16","author":"Brahami","year":"2017","journal-title":"J\u00a0Negat Results Biomed"},{"key":"10.1016\/j.jvsv.2020.07.015_bib5","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1093\/hmg\/ddv349","article-title":"Common and specific effects of TIE2 mutations causing venous malformations","volume":"24","author":"Natynki","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jvsv.2020.07.015_bib6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.282.5388.468","article-title":"Increased vascularization in mice overexpressing angiopoietin-1","volume":"282","author":"Suri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jvsv.2020.07.015_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1034\/j.1399-0004.2003.00092.x","article-title":"Vascular malformations: localized defects in vascular morphogenesis","volume":"63","author":"Brouillard","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.jvsv.2020.07.015_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/lrb.2008.1524","article-title":"HGF and MET mutations in primary and secondary lymphedema","volume":"6","author":"Finegold","year":"2008","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.jvsv.2020.07.015_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.1182868","article-title":"Functional hierarchy and reversibility within the murine spermatogenic stem cell compartment","volume":"328","author":"Nakagaw","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jvsv.2020.07.015_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1096\/fasebj.14.2.399","article-title":"Different point mutations in the Met oncogene elicit distinct biological properties","volume":"14","author":"Giordano","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.jvsv.2020.07.015_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/atm.2016.12.33","article-title":"MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy","volume":"5","author":"Pilotto","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jvsv.2020.07.015_bib12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4161\/cbt.7.6.5842","article-title":"elegans as a model organism for in\u00a0vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes","volume":"7","author":"Siddiqui","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jvsv.2020.07.015_bib13","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/cam4.2782","article-title":"Two point-NGS analysis of cancer genes in cell free-DNA of metastatic cancer patients","volume":"9","author":"Palmieri","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jvsv.2020.07.015_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid biopsy: monitoring cancer-genetics in the blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jvsv.2020.07.015_bib15","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMra1706174","article-title":"Application of cell-free DNA analysis to cancer treatment","volume":"379","author":"Corcoran","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvsv.2020.07.015_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40169-014-0030-5","article-title":"Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer","volume":"3","author":"Sylvester","year":"2014","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jvsv.2020.07.015_bib17","first-page":"6272","article-title":"c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions","volume":"63","author":"Ma","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jvsv.2020.07.015_bib18","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/sj.onc.1202547","article-title":"Novel mutations of the MET proto-oncogene in papillary renal carcinomas","volume":"18","author":"Schmidt","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.jvsv.2020.07.015_bib19","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.18632\/oncotarget.3094","article-title":"Functional consequence of the MET-T1010I polymorphism in breast cancer","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jvsv.2020.07.015_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10637-016-0332-0","article-title":"A\u00a0never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinib","volume":"34","author":"Mahjoubi","year":"2016","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jvsv.2020.07.015_bib21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2147\/OTT.S226951","article-title":"Foretinib inhibits cancer stemness and gastric cancer cell proliferation by decreasing CD44 and c-MET signaling","volume":"13","author":"Sohn","year":"2020","journal-title":"Onco Targets Ther"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X20304613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X20304613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T07:01:36Z","timestamp":1761980496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X20304613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213333X20304613"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2020.07.015","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2020.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}